ART in low-resource settings: how to do more with less

被引：4

作者：

Koole, Olivier ^{[1
]}

Colebunders, Robert ^{[1
,2
]}

机构：

[1] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium

[2] Univ Antwerp, B-2000 Antwerp, Belgium

来源：

LANCET | 2010年 / 376卷 / 9739期

关键词：

1ST-LINE ANTIRETROVIRAL THERAPY; COUNTRIES; MORTALITY; FAILURE; AFRICA;

D O I：

10.1016/S0140-6736(10)61020-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：396 / 398

页数：3

共 14 条

[1]

[Anonymous], 2009, Rapid Advice: Antiretroviral Therapy for HIV Infection in Adults and Adolescents

[2]

Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2

[3]

*CAMP ACC ESS MED, 2009, MED SANS FRONT PUN S

[4]

*COMM SOC DET HLTH, 2008, CLOS GAP EGN HLTH EQ

[5] The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy [J].

Hosseinipour, Mina C. ;

van Oosterhout, Joep J. G. ;

Weigel, Ralf ;

Phiri, Sam ;

Kamwendo, Debbie ;

Parkin, Neil ;

Fiscus, Susan A. ;

Nelson, Julie A. E. ;

Eron, Joseph J. ;

Kumwenda, Johnstone .

AIDS, 2009, 23 (09) :1127-1134

[6] Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design [J].

Lawn, SD ;

Myer, L ;

Orrell, C ;

Bekker, LG ;

Wood, R .

AIDS, 2005, 19 (18) :2141-2148

[7] An Algorithm to Optimize Viral Load Testing in HIV-Positive Patients With Suspected First-Line Antiretroviral Therapy Failure in Cambodia [J].

Lynen, Lutgarde ;

An, Sokkab ;

Koole, Olivier ;

Thai, Sopheak ;

Ros, Seilavath ;

De Munter, Paul ;

Sculier, Delphine ;

Arnould, Line ;

Fransen, Katrien ;

Menten, Joris ;

Boelaert, Marleen ;

Van den Ende, Jef ;

Colebunders, Robert .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 52 (01) :40-48

[8]

MAY M, 2010, LANCET, DOI DOI 10.1016/50140-6736(10)60666-6

[9]

Müller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8

[10] Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial [J].

Mugyenyi, P. ;

Walker, A. S. ;

Hakim, J. ;

Munderi, P. ;

Gibb, D. M. ;

Kityo, C. ;

Reid, A. ;

Grosskurth, H. ;

Darbyshire, J. H. ;

Ssali, F. ;

Bray, D. ;

Katabira, E. ;

Babiker, A. G. ;

Gilks, C. F. ;

Grosskurth, H. ;

Munderi, P. ;

Kabuye, G. ;

Nsibambi, D. ;

Kasirye, R. ;

Zalwango, E. ;

Nakazibwe, M. ;

Kikaire, B. ;

Nassuna, G. ;

Massa, R. ;

Fadhiru, K. ;

Namyalo, M. ;

Zalwango, A. ;

Generous, L. ;

Khauka, P. ;

Rutikarayo, N. ;

Nakahima, W. ;

Mugisha, A. ;

Todd, J. ;

Levin, J. ;

Muyingo, S. ;

Ruberantwari, A. ;

Kaleebu, P. ;

Yirrell, D. ;

Ndembi, N. ;

Lvagoba, F. ;

Hughes, P. ;

Aber, M. ;

Lara, A. Medina ;

Foster, S. ;

Amurwon, J. ;

Wakholi, B. Nyanzi ;

Whitworth, J. ;

Wangati, K. ;

Amuron, B. ;

Kajungu, D. .

LANCET, 2010, 375 (9709) :123-131

← 1 2 →